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The dorsal raphe nucleus (DRN) provides the major source of serotonin to the central 
nervous system (CNS) and modulates diverse neural functions including mood. 
Furthermore, DRN cellular networks are engaged in the stress-response at the CNS level 
allowing for adaptive behavioural responses, whilst stress-induced dysregulation of DRN 
and serotonin release is implicated in psychiatric disorders. Therefore, identifying the 
molecules regulating DRN activity is fundamental to understanding DRN function in health 
and disease. GABAA receptors (GABAARs) allow for brain region, cell-type and subcellular 
domain specific GABA-mediated inhibitory currents and are thus key regulators of 
neuronal activity. Yet, the GABAAR subtypes expressed within the neurochemically diverse 
cell-types of the mouse DRN are poorly described. In this study, immunohistochemistry 
and confocal microscopy revealed that all serotonergic neurons expressed 
immunoreactivity for the GABAAR alpha2 and 3 subunits, although the respective signals 
were co-localised to varying degrees with inhibitory synaptic marker proteins. Only a 
topographically located sub-population of serotonergic neurons exhibited GABAAR alpha1 
subunit immunoreactivity. However, all GABAergic as well as non-GABAergic, non-
serotonergic neurons within the DRN expressed GABAAR alpha1 subunit 
immunoreactivity. Intriguingly, immunoreactivity for the GABAAR gamma2 subunit was 
enriched on GABAergic rather than serotonergic neurons. Finally, repeated restraint stress 
increased the expression of the GABAAR alpha3 subunit at the mRNA and protein level. 
The study demonstrates the identity and location of distinct GABAAR subunits within the 
cellular networks of the mouse DRN and that stress impacts on the expression levels of 






The dorsal raphe nucleus (DRN) provides the major source of serotonin to the central 
nervous system (Jacobs and Azmitia 1992) and modulates the activity of distinct brain 
regions, notably those involved in mood-related functions such as the amygdala and 
prefrontal cortex (Petrov et al. 1994; Vertes 1991) . Allied to its role in mental function is 
the contribution of the DRN in determining adaptive behavioural responses to psychosocial 
stressors (Waselus et al. 2011). Engagement of both the serotonergic and non-
serotonergic  neuronal networks comprising the DRN is integral to processing such various 
forms of stress-related information (Roche et al. 2003; Shikanai et al. 2012; Challis et al. 
2013) resulting in the release of serotonin in a brain region and stimulus specific manner 
(Kirby et al. 1995; Kirby et al. 1997; Adell et al. 1997). Since altered DRN function is 
implicated in stress-related mental illnesses (Baumann et al. 2002), identifying the 
neurotransmitter receptors which underpin cellular communication within the DRN is 
fundamental to understanding the changes in DRN neuronal activity and serotonin release 
during different brain-states or disease profiles.  
 
GABAergic inputs onto serotonergic neurons, which arise locally, or from distant sources 
signalling via GABAARs, appear to play a central role in shaping DRN serotonin neuronal 
activity and stress-induced DRN behaviours (Gervasoni et al. 2000; Celada et al. 2001; 
Challis et al. 2013; Crawford et al. 2013; Soiza-Reilly et al. 2013). Therefore, the precise 
location of distinct GABAAR subtypes is likely to be central to cellular communication 
between the functionally distinct cell-types of the DRN and thus coordinated serotonin 
release. GABAARs are composed of five interacting subunit proteins forming an associated 
anion channel. Nineteen GABAAR subunits have been cloned (Olsen and Sieghart 2009) 
with the subunit combinations determining the biophysical (Farrant and Nusser 2005; 
Belelli et al. 2009; Eyre et al. 2012) and pharmacological (Rudolph and Knoflach 2011) 
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properties of the receptor. As a consequence, the brain-region and cell-type specific 
expression patterns of various GABAAR subunits (Hortnagl et al. 2013; Fritschy and 
Mohler 1995; Wisden et al. 1992) manifest in diverse GABAAR-mediated inhibitory 
currents throughout the brain, the kinetics of which, within the DRN, are influenced by 
psychosocial stressors (Kirby et al. 2008; Crawford et al. 2013).  
 
GABAAR subunit expression patterns have been reported for the rat DRN (Gao et al. 1993; 
Pirker 2000; Fritschy and Mohler 1995), but not the mouse DRN, despite considerable 
inter-species differences in their DRN neurochemistry (Fu et al. 2010). Furthermore, 
although there is a convergence of GABAAR expression (Vithlani et al. 2013) and 
exposure to stress (Binder and Nemeroff 2010) with mental illnesses, it is unclear whether 
stress directly influences GABAAR subtypes expressed within the DRN. Having recently 
shown functional contribution of GABAAR-mediated inhibitory postsynaptic currents to 
DRN serotonergic neuronal excitability (Maguire et al. 2013), this study goes on to 
demonstrate the identity and the location of the GABAAR alpha and gamma2 subunits 
expressed within the cellular networks of the mouse DRN. We also reveal that repeated 
stress results in the selective up-regulation of the GABAAR alpha3 subunit expression at 












Materials and methods 
 
All procedures involving experimental animals were performed in accordance with the 
Animals (Scientific Procedures) Act, 1986 (UK) and associated procedures. Every effort 
was made to minimise any pain or discomfort to the animals. 
 
Animals 
Adult C57BL/6J male mice and transgenic mice which expressed green fluorescent protein 
(GFP) as a reporter molecule driven by the promoter of the gene for the GABA 
synthesising enzyme glutamic acid decarboxylase 67 (GAD67), (GAD67-GFP) (Tamamaki 




Animals were perfusion-fixed as follows: anaesthesia was induced with isofluorane and 
maintained with pentobarbitone (1.25 mg/kg of bodyweight; i.p.). The animals were 
perfused transcardially with 0.9 % saline solution for 1 minute, followed by 12 minutes 
fixation with a fixative consisting of 1% paraformaldehyde, 15% v/v saturated picric acid, in 
0.1 M phosphate buffer (PB), pH 7.4. The brains were kept in the same fixative solution 
overnight at 4°C. Coronal sections of the DRN, 60 µm thick, were prepared on a 
Vibratome and stored in 0.1 M PB containing 0.05% sodium azide. 
 
Immunohistochemical reactions 
Immunohistochemical procedures were according to those used in (Corteen et al. 2011). 
Four C57BL/6J and two GAD67-GFP transgenic animals were used to confirm the native 
patterns of the immunoreactivity. A proteolytic antigen retrieval method was used to 
localise membrane–bound epitopes according to (Watanabe et al. 1998; Lorincz and 
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Nusser 2008). Briefly, the tissue sections were incubated at 37°C for 10 minutes in 0.1 M 
PB followed by 15 minutes in 0.2 M HCl containing 1 mg/ml pepsin (Sigma, UK) after 
which they were washed thoroughly in Tris-buffered saline containing 0.3% triton (TBS-Tx) 
for 30 minutes. Non-specific binding of secondary antibodies was blocked by incubating 
sections with 20% normal horse serum for 2 hours at room temperature. The tissue 
sections were incubated with cocktails of primary antibodies (Table 1), diluted in TBS-Tx, 
overnight at 4°C. After washing with TBS-Tx, sections were incubated in a mixture of 
appropriate secondary antibodies conjugated with either Alexa Fluor 405 (Jackson 
ImmunoReserach) Alexa Fluor 488 (Invitrogen, Eugene, OR), indocarbocyanine (Cy3; 
Jackson ImmunoResearch), and indodicarbocyanine (Cy5; Jackson ImmunoResearch) for 
2 hours at room temperature. Sections were washed in TBS-Tx and mounted in 
Vectashield mounting medium (Vector Laboratories, Burlingame, CA).  
 
Antibody specificity 
Although the specificity of all the antisera against the GABAAR subunits used in this study 
have been reported upon extensively in other publications (see Table 1), tissue from 
GABAAR alpha1 subunit-specific gene deleted mice  (Sur et al. 2001), GABAAR alpha2 
subunit-specific gene deleted mice (Dixon et al. 2008) and GABAAR alpha3 subunit-
specific gene deleted mice (Yee et al. 2005) was used in the current study to confirm the 
specificity of the respective immunoreactivity patterns under current reaction conditions 
and within specific brain regions investigated. Method specificity was also tested by 
omitting the primary antibodies in the incubation sequence. To confirm the absence of 
cross reactivity between IgGs in double and triple immunolabelling experiments, some 
sections were processed through the same immunohistochemical sequence, except that 





Sections were examined with a confocal laser-scanning microscope (LSM710; Zeiss, 
Oberkochen, Germany) using either a Plan Apochromatic 63x DIC oil objective (NA1.4) 
(pixel size 0.13 μm) or a Plan Apochromatic 100x DIC oil objective (NA1.46) (pixel size 
0.08 μm). Z-stacks were used for routine evaluation of the labelling. All images presented 
represent a single optical section. These images were acquired using sequential 
acquisition of the different channels to avoid cross-talk between fluorophores, with the 
pinholes adjusted to one airy unit. Images were processed with the software Zen2008 
Light Edition (Zeiss, Oberkochen, Germany) and exported into Adobe Photoshop. Only 
brightness and contrast were adjusted for the whole frame, and no part of a frame was 
enhanced or modified in any way.  
 
Quantification of the density of gephyrin and neuroligin2 as well as their degree of 
colocalisation on TPH-immunopositive somata and dendrites  
Immunoreactivity for molecular markers of inhibitory synapses, namely gephyrin (Essrich 
et al. 1998) and neuroligin2 (NL2) (Varoqueaux et al. 2004) were used to gain a 
perspective of the location of putative GABAergic synapses on serotonergic neurons within 
the DRN. Tryptophan hydroxylase (TPH) immunoreactivity was used to visualise 
serotonergic neurons. The quantitative method used is according to our previous reports 
(Corteen et al. 2011; Gunn et al. 2013; Maguire et al. 2013). A total of 9 tissue sections, 3 
per animal, 3 animals, were used to quantify: 1) the density of individual gephyrin and NL2 
immunoreactive clusters on TPH immunopositive profiles; 2) the density of gephyrin and 
NL2 immunoreactive clusters which colocalised with one another and; 3) the proportion of 
individual gephyrin and NL2 immunoreactive clusters which were located on either TPH-
immunopositive somata or dendrites. Preliminary investigations revealed no discernible 
gradients in the intensity of gephyrin and NL2 signals in the rostro-caudal planes. 
Therefore, tissue sections at the rostral-caudal midline level of the DRN (Bregma ~ -4.60) 
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from each animal were selected for analyses. Two fields of view (FOV) were randomly 
selected within the DRN ventromedial sub-region of each tissue section. A Z-stack 
consisting of three optical sections was acquired for each FOV with a Plan Apochromatic 
x100 (NA1.4) DIC oil immersion objective. The dimensions of the optical sections were 
84.94µm x 84.94µm in the X & Y planes and 1 µm thick in the Z plane. Optical sections 
were spaced 2 µm apart. In all cases, triple immunofluorescence (TPH-neuroligin2-
gephyrin) was acquired using sequential acquisition of the different channels. The number 
of individual clusters (gephyrin or NL2) within an optical section associated with TPH 
immunoreactivity was manually counted using ImageJ software and the density 
determined by dividing the number of clusters by the area of the optical section. Co-
localisation of individual clusters (gephyrin and NL2) from the different channels was 
visually confirmed in the X, Y and orthogonal planes and manually counted using ImageJ 
and the density then calculated. Finally, the proportion of NL2 and gephyrin 
immunoreactive clusters located on either somatic or dendritic compartments was 
determined.  
 
Quantification of the relative proportion of TPH-immunopositive cells expressing GABAAR 
alpha1 subunit immunoreactivity 
A previous study of the rat reported that the GABAAR alpha1 subunit is predominantly 
expressed by GABAergic non-serotonergic neurons and to a lesser extent by serotonergic 
neurons in the DRN (Gao et al. 1993). Preliminary investigations confirmed this similar 
restricted expression pattern of this subunit in the DRN of the mouse. However, it was 
noticeable that the TPH-GABAAR alpha1 subunit immunopositive neurons were not 
randomly distributed throughout the mouse DRN, but were concentrated within specific 
sub-regions of the nucleus. We therefore quantified the ratio of TPH-GABAAR alpha1 
subunit immunopositive cells to total TPH immunopositive cells as well as the location of 
this population of cells, in three animals, nine tissue sections per animal which were 70 
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µm-thick. For a particular animal, three sections representing either the rostral (~ -4.24 mm 
Bregma), midline (~ -4.6 mm Bregma) or caudal (~ -4.96 mm Bregma) (total of nine tissue 
sections per animal) extents of the DRN were used for quantification. This was repeated in 
3 animals. For each tissue section, the proportion of TPH-GABAAR alpha1 subunit 
immunopositive cells to total TPH-immunopositive cells was quantified within the distinct 
sub-regions of the DRN. For the rostral sections, the DRN was subdivided into dorsal 
(dDRN) ventral (vDRN) and medial interfasicular (ifDRN) regions. For the midline sections, 
the DRN was subdivided into dorsal, ventral, medial interfasicular and lateral (lDRN) 
regions. For the caudal sections, the DRN was subdivided into dorsal, ventral regions and 
medial interfasicular regions. To unequivocally confirm that GABAAR alpha1 subunit 
immunoreactive clusters were located on TPH-immunopositive neurons, Z-stacks were 
acquired throughout the full extent of the tissue section using a Plan Apochromatic 63X 
DIC oil objective (NA1.3). The dimensions of the optical sections were 224 µm x 224 µm x 
0.9 µm (X, Y, Z). The optical sections within a Z-stack were spaced 7 µm apart in the Z-
plane with 0.5 µm overlap between optical sections. ImageJ software (NIH) was used to 
manually count the number of TPH-GABAAR alpha1 subunit-immunopositive neurons in 
relation to the total number of TPH-immunopositive cells within the different DRN sub 
regions. The mean ± SEM number of total TPH and TPH-GABAAR alpha1 subunit-
immunopositive cells within the DRN sub-nuclei at rostral, midline and caudal planes of  
three animals are presented as well as the proportion of TPH-GABAAR alpha1 subunit-





Quantification of the relative proportion of NL2 immunoreactive clusters which co-localise 
with GABAAR alpha2 & 3 subunit immunoreactive clusters on TPH-immunopositive somata 
and dendrites 
The quantitative method used is according to our previous report (Corteen et al. 2011). 
Tissue from five animals (three tissue sections per animal) was used to quantify the 
relative proportion of NL2 immunoreactive clusters which co-localised with GABAAR 
alpha2 and GABAAR alpha3 subunit immunoreactive puncta on TPH-immunopositive 
dendrites and somata with the intention of estimating what proportion of inhibitory 
synapses on such cell surfaces are likely to contain GABAARs composed of these 
subunits. Preliminary investigations revealed no discernible gradients in the intensity for 
signal for either the GABAAR alpha2 or GABAAR alpha3 subunits in the rostro-caudal 
planes. Therefore, tissue sections at the rostral-caudal midline level of the DRN from each 
animal were selected for each of the following immunohistochemical reactions: 1) TPH-
GABAAR alpha2 subunit-NL2 and; 2) TPH-GABAAR alpha3 subunit-NL2.  Two fields of 
view (FOV) were randomly selected within the DRN ventromedial sub-region of each 
tissue section. A Z-stack consisting of three optical sections was acquired for each FOV 
with a Plan Apochromatic x100 (NA1.4) DIC oil immersion objective. The dimensions of 
the optical sections were 84.94µm x 84.94µm in the X & Y planes and 1 µm thick in the Z 
plane. Optical sections were spaced 2 µm apart. In all cases, triple immunofluorescence 
(TPH-NL2-alpha2 or TPH-NL2-alpha3) was acquired using sequential acquisition of the 
different channels. The number of clusters within an optical section associated with TPH 
immunoreactivity was manually counted using ImageJ software. Co-localisation of 
individual clusters from the different channels was visually confirmed in the X, Y and 
orthogonal planes and manually counted using ImageJ. The proportion of NL2 clusters 
which co-localised with either GABAAR alpha2 or alpha3 subunit clusters was computed 
and expressed as the number of puncta per 1000 um2 of DRN.   
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Repeated restraint stress 
The DRN-5HT system is central to integrating  stress-related information within the CNS 
and the adoption of adaptive or maladaptive behavioural responses (Waselus et al. 2011) 
with GABAAR functional plasticity within the cellular networks of the DRN central to such 
processes (Crawford et al. 2013; Kirby et al. 2008; Kirby et al. 2000). However, it is 
currently unclear whether exposure to stress directly impacts on the level of expression of 
particular GABAAR subtypes and the particular cell-types involved. With  a view to 
investigating potential GABAAR plasticity in adaptive, rather than maladaptive responses to 
stressful experiences, we deliberately used a mild restraint stress protocol which does not 
induce a chronic stress phenotype (Buynitsky and Mostofsky 2009) nor anxiogenic-like 
behaviour (Seifi et al. 2014).  However, this protocol has been shown to robustly engage 
the DRN-serotonergic system, amongst other brain regions (Shoji and Mizoguchi 2010; 
Keshavarzy et al. 2014). Animals were divided into stress and control experimental groups 
one week prior to the start of the experiment in order to allow adaptation to the new cage 
environment before commencing the stress, To deliver restraint, mice aged postnatal day 
(PND) 40 were inserted tail first into a Broome rodent restrainer (Harvard Apparatus # 52-
0470) for 30 minutes per day. Mice were restrained within the tube, but not fully 
immobilised. They thus were able to move slightly backwards and forwards in the device. 
During restraint stress, mice were kept individually in standard housing cages containing a 
thin layer of corn cob. After the restraint stress, animals were removed to their home 
cages. The restraint stress was delivered at set times during the day for eight consecutive 
days. The time-period of eight days was chosen empirically as the minimum length of time 
required to reliably induce statistically significant changes in animal behaviour and 
GABAAR subunit expression, based on pilot experiments. To prevent habituation to the 
repeated stressor over the course of the experiment, the duration and the degree of 
restraint was subtly varied between days, as detailed in Table 2. To apply escapable 
restraint, the animal was inserted into the tube and restrained for 1 minute, after which the 
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stopper was removed and the animal was able to emerge from the restrainer and explore 
the novel environment of the cage, with the restrainer left in the cage. Control mice 
remained in their original cages and were left undisturbed in this home environment. On 
day 9 the tissue from control and stress animals was processed for either GABAAR mRNA 
or immunohistochemical analyses.  
 
Quantitative reverse transcription polymerase chain reaction (qRT-PCR)  
To assess how stress might impact upon the mRNA encoding GABAAR subunits within the 
DRN, one day after the final stress episode (day 9), the mice were euthanized  by cervical 
dislocation and their brains rapidly removed. Fourteen control and fourteen stress animals 
were used for these analyses. Two millimetre thick tissue sections containing the DRN 
were obtained using a brain matrix (Harvard apparatus; #726233). From these sections, a 
tissue punch of 2 mm diameter was used to extract the DRN which was then placed in 
RNAlater® for post hoc RNA extraction. Each tissue punch was removed from the 
RNAlater® and placed in RLT lysis buffer (Qiagen) and was disrupted with a rotor 
homogeniser. Total RNA was extracted from the tissue lysate using RNeasy® RNA 
Purification kit (Qiagen) according to the manufacturer’s instructions. Subsequently, 
purified RNA was reverse transcribed to cDNA at 37 °C using M-MuLV reverse 
transcriptase and Oligo(dT)18 primers.  
 
Multiplex qPCR 
Multiplex qPCR was used to simultaneously analyse the expression of both the 
housekeeping gene (Gapdh) and a second gene of interest. The genes investigated were: 
Gabra1 (the GABAAR alpha1 subunit); Gabra2 (the GABAAR alpha2 subunit); Gabra3 (the 
GABAAR alpha3 subunit), and Gabrg2 (the GABAAR gamma2 subunit). qPCR was 
performed according to Carter et al. (2013); for each sample 2 µl cDNA was mixed with 
nuclease free water, mastermix (Roche) and the primers and probes of housekeeping 
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gene and gene of interest, tagged with VIC (primer limited) and FAM respectively, to yield 
a 10 µl total reaction volume. The primers and probes used in this study are displayed in 
Table 3.  The qPCR was performed under the following cycling conditions: 95°C for 10 
minutes and 55 cycles of 95°C for 10 sec and 60°C for 30 sec. 
  
Analysis of RNA expression levels 
The relative standard curve method was used for quantitative determination of the amount 
of the gene of interest in relation to the amount of the housekeeping gene (Gapdh). 
Standard curves were generated for Gabra1, Gabra2, Gabra3, and Gabrg2 using serial 
dilutions of cDNA from whole mouse brain. Each measurement was performed in triplicate 
and each Ct value was then converted into ng RNA using linear regression analysis of the 
standard curve (Microsoft Excel). Each ng RNA value was normalised against the ng 
housekeeping gene level within the same sample. Mean ng RNA levels were computed 
from the normalised measurements and compared across stress and control experimental 
groups. qRT-PCR data is presented as relative change in gene expression above or below 
control. 
 
Quantification of the relative proportion of GABAAR alpha3 subunit and gephyrin 
immunoreactive clusters on TPH immunopositive somata and dendrites in tissue from 
repeated restraint stress and control mice 
One day after the final stress episode (day 9), tissue was prepared for 
immunohistochemical analyses as above using three control and three stress animals. The 
quantitative method used to identify how stress influences GABAAR subunit expression in 
the DRN is according to Lorenzo et al. (2007). Tissue from six animals, three stress and 
three control, were used to quantify the relative proportion and degree of co-localisation of 
GABAAR alpha3 subunit and gephyrin immunoreactive puncta on TPH-immunopositive 
dendrites and somata. Tissue sections at the rostra-caudal midline level of the DRN 
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(approximately -4.60 Bregma) from each animal were selected for the following 
immunohistochemical reaction: TPH-GABAAR alpha3 subunit-gephyrin. Two fields of view 
(FOV) were randomly selected within the ventromedial sub-region of each tissue section. 
The ventromedial sub-region was selected because of data within this study showing that 
inhibitory innervation is enriched on the dendritic domains of TPH-immunopositive neurons 
and TPH dendrites are densest within the ventromedial sub-region. A Z-stack consisting of 
three optical sections was acquired for each FOV with a Plan Apochromat x100 (NA1.4) 
DIC oil immersion objective. The dimensions of the optical sections were 84.94 µm x 84.94 
µm in the X & Y planes and 1 µm thick in the Z plane. Optical sections were spaced 2 µm 
apart. Triple immunofluorescence was acquired using sequential acquisition of the 
different channels. The number of GABAAR alpha3 subunit, gephyrin and co-localised 
GABAAR alpha3 subunit-gephyrin clusters within an optical section associated with TPH 
immunoreactivity was manually counted using ImageJ (NIH) software. The numbers of 
clusters for each optical section within a field of view were combined and the means ± SD 
for all FOV within and between sections were pooled within either control or stress groups. 
Quantitative data are reported as density of clusters per 1000 um2.  
 
Statistical analysis 
All quantitative data are presented as the mean ± SEM unless otherwise stated. The data 
were tested for normality using a Shapiro-Wilk test.  An Independent Student’s T-test or 
Mann-Whitney test was used for normally and non-normally distributed data, respectively. 
In all cases, SPSS was used for statistical analyses. GraphPad was used for graphical 




Inhibitory synaptic marker proteins are preferentially located on dendritic compartments of 
DRN serotonergic neurons  
 
Molecular markers of inhibitory synapses were used to initially gain a perspective of the 
location of putative GABAergic synapses on the somatic and dendritic domains of 
serotonin neurons within the DRN. Immunolabelling for gephyrin, a protein enriched in 
inhibitory synapses due to its role in clustering GABAARs and strychnine-sensitive glycine 
receptors (Essrich et al. 1998), was widely associated with TPH-immunopositive profiles, 
although immunoreactive clusters appeared to be preferentially located on dendritic rather 
than their somatic compartments (Fig. 1a1). Immunoreactivity for NL2 (Fig. 1a2), a protein 
exclusively expressed at inhibitory synapses (Varoqueaux et al. 2004) (Poulopoulos et al. 
2009) closely matched the pattern of gephyrin. Both gephyrin and NL2 immunoreactivity 
displayed significant co-localisation throughout the rostral-caudal and dorsal-ventral 
extents of the DRN (Fig. 1a3). Quantification of gephyrin immunoreactivity revealed that 
(mean ± SEM) 37.7 ± 2.7 clusters per 1000 µm2 were located on TPH immunopositive 
profiles, of which, 7% were located on somata and 93% on dendrites. Furthermore, 
quantification of NL2 immunoreactivity revealed that (mean ± SEM) 55.4 ± 4.9 clusters per 
1000 µm2 were located on TPH immunopositive profiles of which, 7% were located on 
somata and 93% on dendrites. Finally, the density of colocalised gephyrin-NL2 
immunopositive clusters was (mean ± SEM) 29 ± 3  clusters per 1000 µm2 which 
computes to 76% of gephyrin immunoreactive clusters being colocalised with those 
immunoreactive for NL2 whereas 53% of NL2 immunoreactive clusters colocalised with 
those immunoreactive for gephyrin (Fig. 1b).  
 
Data on only the GABAAR alphas 1, 2, 3 and gamma2 subunits are presented since we 
found no evidence for the expression of the GABAAR alpha 4, 5 and delta subunits in the 
16 
 
DRN, whilst the expression of all other subunits (beta; gamma1, 3; epsilon; pi) was not 
investigated. The specificity of the antibodies against either the GABAAR alpha1, alpha2 or 
alpha3 subunits was confirmed in tissue from wild-type (WT) mice and tissue from either 
GABAAR alpha1 (Fig. 2a, b), alpha2 (Fig. 2c, d) or alpha3 (Fig. 2e, f) subunit-specific 
gene-deleted mice respectively. There were no discernible differences in the intensity of 
TPH immunoreactivity in the DRN of WT and GABAAR alpha1, alpha2 or alpha3 subunit-
specific gene-deleted mice suggesting that the absence of these subunits did not impact 
on the expression of this enzyme within the DRN (Fig. 2). 
 
The GABAAR alpha1 subunit is expressed by a minority of serotonin neurons and all 
GABAergic neurons within the DRN 
GABAAR alpha1 subunit immunoreactivity was evident throughout the DRN in both rostral-
caudal and dorso-ventral extents although it appeared to be enriched particularly in the 
lateral wing sub-regions (Fig. 2a2). Numerous GABAAR alpha1 subunit immunoreactive 
profiles were interspersed between those immunopositive for TPH, demonstrating the 
multitude of cells which expressed this subunit within the DRN (Fig. 3a1). The GABAAR 
alpha1 subunit signal was equally enriched on somatic as well as dendritic compartments 
of cells as demonstrated by its high degree of co-localisation with the dendritic marker 
protein microtubule associated protein (MAP-2) (Fig. 3a2, 3). This location of the GABAAR 
alpha1 subunit signal on neuronal somata is in stark contrast to the signal for the GABAAR 
alphas 2 and 3 subunits which was preferentially restricted to dendritic domains (see 
below). A previous study in the DRN of the rat reported that the GABAAR alpha1 subunit is 
mainly expressed by non-serotonergic, GABAergic neurons of the DRN (Gao et al. 1993). 
GABAAR alpha1 subunit immunoreactive signal was localised to three neurochemically 
diverse cell types within the DRN (Fig. 3b,c); i) a sub-population of TPH-immunopositive 
neurons which displayed GABAAR alpha1 subunit signal on their somata (Fig. 3b1); ii) all 
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GFP-GAD67 immunopositive neurons (Fig. 3B2) and; iii) a population of DRN neurons 
which were immunonegative for both TPH and GAD67-GFP (Fig. 3b3).  
 
Double labelling with gephyrin revealed extensive co-localisation between gephyrin and 
GABAAR alpha1 subunit immunoreactivity (Fig. 3b3). The gephyrin signal was 
predominantly enriched on dendritic domains, apart from a subpopulation of GAD67-GFP 
immunolabelled neurons situated within the ventral DRN, which, qualitatively, exhibited 
uncharacteristically intense somatic gephyrin signal. Qualitative observations revealed that 
these ventral GAD67-GFP neurons were also much larger than dorsal GAD67-GFP 
neurons (Fig. 3c3). This distribution and diverse morphology could suggest the presence 
of at least two sub-populations of GABAergic neurons within the DRN; i) one population 
which possesses lower levels of synaptically localised alpha1 subunit containing GABAARs 
(alpha1-GABAARs) on their somata and; ii) a second sub-population, which possess 
higher levels of synaptically localised alpha1-GABAARs on their somata. The 
predominance of GABAAR alpha1 subunit signal on most of the non-TPH immunopositive 
neurons suggests that GABAARs containing this subunit will have a major influence on the 
excitability and function of these neurons, which are thought to provide local circuit 
inhibition onto the principal serotonergic neurons of the DRN. Therefore, while  alpha1-
GABAARs are not widely expressed on serotonin neurons, their modulation in vivo, for 
example with subunit-specific ligands such as zolpidem, could have a profound impact 
upon brain serotonin levels, by altering the levels of GABA released onto serotonergic 
neurons. 
 
The ratio of TPH-GABAAR alpha1 subunit immunopositive cells to those TPH 
immunopositive cells which did not express this subunit was quantified throughout the 
rostro-caudal axis of the DRN (Fig. 4a-c). TPH-GABAAR alpha1 subunit immunopositive 
cells were enriched at the rostral extent of the DRN (Bregma ~ -4.24) (Fig. 4a1), with ~ 
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21% of TPH labelled cells in rostral DRN also displaying the GABAAR alpha1 subunit 
signal (mean ± SEM, total number of TPH immunopositive cells, 220 ± 35 versus TPH-
GABAAR alpha1 subunit immunopositive cells, 46 ± 6, N = 3 animals) (Fig. 4a3). Of the 
cells counted at this rostral location the following numbers (mean ± SEM) were located 
within these specific DRN sub-nuclei; a) dDRN, total number of TPH immunopositive cells, 
66 ± 14 versus TPH-GABAAR alpha1 subunit immunopositive cells, 18 ± 4; b) vDRN, total 
number of TPH immunopositive cells, 77 ± 33 versus TPH-GABAAR alpha1 subunit 
immunopositive cells, 13 ± 6; c) ifDRN, total number of TPH immunopositive cells, 85 ± 17 
versus TPH-GABAAR alpha1 subunit immunopositive cells, 15 ± 2 (Fig. 4 a2).  
 
The proportion of TPH labelled cells which co-expressed the GABAAR alpha1 subunit 
signal decreased considerably from the rostral to caudal planes. Although the midline DRN 
(Bregma ~ -4.60) (Fig. b1) has the majority of TPH immunopositive cells, only ~ 7% of 
TPH labelled cells co-labelled for the GABAAR alpha1 subunit (mean ± SEM, total number 
of TPH immunopositive cells, 728 ± 54 versus TPH-GABAAR alpha1 subunit 
immunopositive cells, 50 ± 4, N = 3 animals) (Fig. 4b3). Of the cells counted at this DRN 
midline location the following numbers (mean ± SEM) were located within these specific 
DRN sub-nuclei; a) dDRN, total number of TPH immunopositive cells, 172 ± 32 versus 
TPH-GABAAR alpha1 subunit immunopositive cells, 19 ± 6; b) vDRN, total number of TPH 
immunopositive cells, 246 ± 47 versus TPH-GABAAR alpha1 subunit immunopositive cells, 
13 ± 4; c) ifDRN, total number of TPH immunopositive cells, 109 ± 11 versus TPH-
GABAAR alpha1 subunit immunopositive cells, 3 ± 2; d) lDRN,  total number of TPH 
immunopositive cells, 219 ± 24 versus TPH-GABAAR alpha1 subunit immunopositive cells, 
17 ± 5 (Fig. 4 b2). 
 
TPH and GABAAR alpha1 subunit immunopositive cells were least abundant in caudal 
DRN (Bregma ~ -4,96) (Fig. 4c1), with only ~ 5% of TPH labelled cells also displaying 
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immunoreactivity for the GABAAR alpha1 subunit (mean ± SEM, total number of TPH 
immunopositive cells, 244 ± 46 versus TPH-GABAAR alpha1 subunit immunopositive cells, 
11 ± 4, N = 3 animals) (Fig. 4c3). Of the cells counted at this DRN caudal location the 
following numbers (mean ± SEM) were located within these specific DRN sub-nuclei; a) 
dDRN, total number of TPH immunopositive cells, 174 ± 35 versus TPH-GABAAR alpha1 
subunit immunopositive cells, 7 ± 4; b) vDRN, total number of TPH immunopositive cells, 
122 ± 34 versus TPH-GABAAR alpha1 subunit immunopositive cells, 10 ± 2; c) ifDRN, total 
number of TPH immunopositive cells, 90 ± 10 versus TPH-GABAAR alpha1 subunit 
immunopositive cells, 4 ± 1 (Fig. 4 c2). Considering the extensive topographical 
organisation of the DRN serotonergic neurons in terms of their efferent outputs, with 
neurons located in different sub-divisions providing serotonergic supply to disparate brain 
regions (Vertes 1991; Lee et al. 2003; Xu and Hokfelt 1997), the distribution pattern of the 
GABAAR alpha1 subunit signal on TPH immunopositive neurons could have a highly 
specific influence over DRN-serotonin mediated regulation of distinct brain regions. 
 
GABAAR alpha2 subunit immunoreactivity is predominantly located on the dendrites of 
serotonergic neurons  
Whilst the immunoreactivity pattern of the GABAAR alpha1 subunit appeared continuous, 
or clustered along somatic and dendritic plasma membranes (Fig. 3), immunoreactivity for 
the GABAAR alpha2 subunit was wholly clustered and located predominantly on TPH 
immunolabelled dendrites, with fewer clusters located on cell bodies (Fig. 5a2). 
Immunoreactivity of the GABAAR alpha2 subunit exhibited the highest degree of co-
localisation with the inhibitory synaptic marker protein NL2 out of all subunits examined 
(Fig. 5b). The density (mean ± SEM number of clusters per 1000 µm2) of NL2 
immunoreactive clusters located on TPH immunopositive profiles was 57.5 ± 2.4 of which 
26.3 ± 1.6 were co-localised with GABAAR alpha2 subunit immunoreactive puncta which 
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suggests that within the DRN, alpha2-subunit containing GABAARs (alpha2-GABAARs) are 
located in ~ 45% of putative inhibitory synapses located on serotonergic neurons.  
 
The GABAAR alpha3 subunit is expressed on serotonergic and GABAergic neurons of the 
DRN 
An overview of the midbrain region containing the DRN revealed that GABAAR alpha3 
subunit immunoreactivity was closely associated with that of TPH illustrating the significant 
expression of this subunit on serotonergic neurons (Fig. 2e2). GABAAR alpha3 subunit 
signal appeared clustered (Fig. 6a2). However, in contrast to the relatively uniformly sized 
clusters of the GABAAR alpha2 subunit, qualitative observations revealed the GABAAR 
alpha3 subunit immunopositive clusters to be notably more variable in both size and 
shape. Compared with the GABAAR alpha2 signal, fewer NL2 immunoreactive clusters 
(Fig. 6a1) co-localised with those of the GABAAR alpha3 subunit (Fig. 6a3): the density 
(mean ± SEM number of clusters per 1000 µm2) of NL2 immunoreactive clusters located 
on TPH immunopositive profiles was 47.7 ± 0.3 of which 13 ± 2 were co-localised with 
GABAAR alpha3 subunit immunoreactive puncta which suggests that within the DRN, 
alpha3-GABAARs are located in ~ 27% of putative inhibitory synapses located on 
serotonergic neurons. The antibodies against the GABAAR alpha2 & 3 subunits were both 
raised in the same species thus precluding double labelling experiments to ascertain the 
degree, if any, of co-localisation between clusters immunoreactive for these subunits. 
Such data would provide a perspective as to whether these subunits are targeted to 
overlapping or distinct populations of synapses on serotonergic neurons, as is the case for 
noradrenergic neurons in the locus coeruleus (Corteen et al. 2011).   
 
A considerable proportion of GABAAR alpha3 subunit immunopositive clusters did not 
appear to co-localise with clusters immunoreactive for NL2. This finding could denote 
either the presence of extrasynaptically located alpha3-GABAAR subtypes on the 
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serotonergic neurons of the DRN, similar to other brain regions (Marowsky et al. 2012), or 
the reaction conditions employed did not optimally allow for the detection of the 
synaptically located GABAAR alpha3 subunit signal. To examine the latter, we performed 
parallel reactions using tissue containing the thalamic reticular nucleus (nRT), since this 
brain region, in adulthood, exclusively expresses the GABAAR alpha3 subunit within 
inhibitory synapses (Fritschy 1998; Browne et al. 2001; Studer et al. 2006) (Fig. 6b). 
Predictably, parvalbumin immunopositive profiles of the nRT (Fig. 6b1) were decorated by 
GABAAR alpha3 subunit immunoreactive clusters (Fig. 6b2) which displayed complete co-
localisation with NL2 (Fig. 6b3). This disparate immunolocalisation pattern of the GABAAR 
alpha3 subunit across different brain regions provides evidence for a brain region and cell-
type specific expression profile of the GABAAR alpha3 subunit.  
 
Within the DRN, we also observed a proportion of GABAAR alpha3 subunit clusters which 
was not associated with TPH immunopositive profiles. In order to identify which non-
serotonergic cell types express the GABAAR alpha3 subunit in the DRN, quadruple 
immunofluorescence for TPH, the GABAAR alpha1 subunit, the GABAAR alpha3 subunit 
and GFP was performed using tissue from the GAD67-GFP mouse model (Fig. 6c). 
Relatively sparse GABAAR alpha3 subunit puncta co-localised with GABAAR alpha1 
subunit puncta on non-TPH profiles in the DRN (Fig. 6c1, 2). This GABAAR alpha3 subunit 
immunoreactivity was localised to GAD67-GFP immunopositive somata and GABAAR 
alpha1 subunit labelled dendrites (Fig 6c3, 4). At least a proportion of GABAAR alpha3 
subunit immunopositive non-serotonergic neurons were GABAergic. However, because 
GAD67-GFP immunoreactivity did not label distal dendrites of GABAergic neurons of the 
DRN, we cannot rule out the possibility that a third, non-serotonergic, non-GABAergic, cell 




Compensatory changes in the levels of co-expressed GABAAR subunits in various brain 
regions have been reported following the constitutive deletion of a particular subunit (Peng 
et al. 2002; Schneider Gasser et al. 2007; Kralic et al. 2006).  In order to assess whether 
such changes occur in the DRN, the level of GABAAR alpha3 subunit immunoreactivity 
was compared in tissue from WT and alpha1-/- (Fig.7a) or alpha2-/- (Fig. 7b) mice. There 
was a striking increase in the intensity of GABAAR alpha3 subunit immunoreactivity in the 
DRN, on both TPH immunopositive and immunonegative profiles of alpha1-/- mice (Fig. 
7b1-3) compared to WT mice (Fig. 7a1-3). Such changes need to be borne in mind when 
assessing alterations in DRN function from alpha1-/- mice. In contrast, no difference was 
detected in the intensity of GABAAR alpha3 subunit immunoreactivity in the DRN of 
alpha2-/- mice (data not shown).   
 
The GABAAR gamma2 subunit is enriched on non-serotonergic neurons 
Within the DRN, GAD67-GFP immunopositive neurons exhibited the highest levels of 
GABAAR gamma2 subunit immunoreactivity (Fig. 8a2) with the signal being localised to 
somatic and dendritic compartments on these putative GABAergic neurons (Fig. 8a1). 
Furthermore, widespread co-localisation between the GABAAR alpha1 and gamma2 
subunit signal on GAD67-GFP immunopositive neurons was evident (Fig. 8a3, 4) as well 
as on TPH-immunopositive profiles which co-localised with GABAAR alpha2 and alpha3 
subunit signals (Fig. 8b, c).  
 
CRH immunoreactive puncta are associated with GABAAR molecular machinery on 
serotonergic and non-serotonergic neurons of the DRN 
DRN neuronal activity is influenced by stress and the effect of stress on serotonin release 
in DRN projection regions is both stressor and brain region specific (Adell et al. 1997). 
Within the DRN, information related to stressful stimuli is conveyed predominantly by the 
stress neuropeptide corticotrophin releasing hormone (CRH) which, in the rat, is contained 
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in axon terminals and cell bodies (Valentino et al. 2001; Waselus et al. 2005). The bath 
application of CRH to acute brain slices containing the DRN decreases serotonergic 
neuronal activity by enhancing both the local release of GABA as well as the postsynaptic 
GABA receptor sensitivity (Kirby et al. 2008). Furthermore, the intracerebroventricular 
administration of CRH directly influences DRN neuronal excitability and serotonin release 
in DRN target fields (Price et al. 1998; Price and Lucki 2001; Kirby et al. 2000). We 
therefore investigated a possible anatomical basis for an interaction between mouse DRN 
GABAAR and CRH systems by examining the association of the GABAAR molecular 
machinery, with that of CRH on the cell types of the DRN. CRH immunoreactive profiles 
were closely opposed to a sub-population of gephyrin-immunoreactive puncta located on 
TPH immunopositive profiles (Fig. 9a1-3), as well as being closely opposed to GABAAR 
alpha1 subunit immunoreactivity which outlined the membrane of a non-TPH neuron (Fig. 
9b). This suggests that within the DRN, CRH is released into a sub-population of GABAAR-
containing synapses on both principal and non-principal neurons.  
 
Repeated stress alters GABAAR expression at the mRNA level in a subunit specific 
manner 
Since stress has been shown to influence DRN neuronal activity (Lemos et al. 2011; Wood 
et al. 2013) this raises the question as to whether stress has a direct effect on DRN 
GABAAR expression. If so, identifying the GABAAR subtypes which underlies such stress-
induced plasticity of the DRN will be vital in devising therapeutic strategies against stress-
related mental illnesses. We therefore investigated whether stress directly influences the 
expression profile of specific GABAAR subunits within the DRN. Repeated stress 
significantly increased the level of expression of the mRNA encoding for the GABAAR 
alpha2 subunit by 13% (N=14 animals; p = 0.007; Student’s T test) and that of the 
GABAAR alpha3 subunit by 27% (N=14 animals; p = 0.011; Student’s T test). However, 
exposure to stress had no significant effect on the level of the mRNA encoding for the 
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GABAAR alpha1 subunit (N=14 animals; p = 0.365; Student’s T test) and the GABAAR 
gamma2 subunit (N=14 animals; p = 0.386; Student’s T test) (Fig. 10a). We then 
investigated whether this stress-induced increase in the GABAAR alpha3 subunit encoding 
mRNA translated to a change in GABAAR alpha3 subunit expression at the protein level on 
TPH immunopositive profiles of the DRN. Exposure to stress significantly increased the 
density of GABAAR alpha3 subunit immunoreactive clusters located on TPH-
immunopositive profiles (mean ± SEM; control, 32 ± 0.5 clusters per 1000um2 versus 57 ± 
0.7 clusters per 1000um2; p <0.001, Mann Whitney; N = 3 control animals, 3 stress 
animals) (Fig. 10b, c). Thus, this stress paradigm increased the expression of the GABAAR 
alpha3 subunit within the DRN at both the mRNA and protein level.  
 
To speculate on the functional contribution of such a stress-induced increase in GABAAR 
alpha3 subunit expression on serotonergic neuronal activity, we quantified the changes in 
the degree of co-localisation between GABAAR alpha3 subunit-immunoreactive clusters 
and gephyrin, a synaptic anchoring protein. Gephyrin directly interacts with the GABAAR 
alpha3 subunit (Tretter et al. 2011) and can therefore be used to infer potential changes in 
synaptic/extrasynaptic density ratios. Stress did not produce a change in the mean ± SEM 
density (number of cluster per 1000 µm2) of gephyrin immunoreactive clusters localised to 
TPH immunolabelled profiles (control, 28 ± 0.6 versus stress, 29 ± 0.3; p = 0.480 , Mann 
Whitney; N = 3 control animals and 3 stress animals). However, stress increased the mean 
density ± SEM (number of clusters per 1000 µm2) of GABAAR alpha3 subunit 
immunoreactive clusters which were co-localised with those immunoreactive for gephyrin 
on TPH immunopositive profiles (control, 6 ± 0.4 versus stress, 10 ± 0.2; p = 0.019, Mann 
Whitney; N = 3 control and 3 stress animals). A proportion of GABAAR alpha3 subunit 
immunoreactive clusters were not co-localised with those immunoreactive for gephyrin and 
probably represent an extrasynaptic pool of alpha3 subunit containing GABAAR subtypes. 
Repeated stress significantly increased the mean density ± SEM (number of clusters per 
25 
 
1000um2) of these GABAAR alpha3 subunit immunoreactive clusters which did not co-
localise with gephyrin (control, 27 ± 0.4 versus stress, 46 ± 0.6; p < 0.001, Mann Whitney; 
N = 3 control and 3 stress animals) (Fig. 10d). Collectively, these data suggest that stress 
increases both the putative synaptic and extrasynaptic pools of alpha3-GABAAR subtypes 



























The study demonstrates the diversity in the regional, cell-type and domain specific 
expression patterns of four GABAAR subunits within the mouse DRN and that the repeated 
stress paradigm used in this study directly influences the level of expression of specific 
GABAAR subunits at the mRNA and protein levels, on individual, identified cell-types. 
Collectively, these data demonstrate the rich molecular repertoire of the GABAAR 
apparatus within the neurochemically and functionally diverse cell-types of the DRN and 
that the expression levels of specific GABAAR subtypes can be shaped by the 
environment. We recently reported on the relative contributions of GABAAR-mediated 
phasic and tonic inhibitory postsynaptic currents to serotonergic neuronal excitability at the 
single cell level (Maguire et al. 2013). Therefore, this expression analysis provides a 
platform for investigating and interpreting the eventual influence of these specific GABAAR 
subtypes on the DRN-serotonin system in the context of intact DRN cellular networks in 
the behaving animal.  
 
The potential role GABAAR alpha1 subunit in the DRN networks  
 
GABAAR alpha1 subunit immunoreactivity within the DRN was confined to all cells which 
expressed the molecular signature of GABA, namely GAD67, as well as a population of 
TPH-immunopositive neurons located preferentially in rostral regions of the DRN. The 
prediction arising from this expression pattern is that the activation of alpha1-GABAARs on 
these different cell-types, the subsequent dampening of excitability and the consequent 
reduced quantal release of GABA, will have contrasting effects on serotonin release from 
the DRN due to the divergent projection patterns of these alpha1-GABAAR immunopositive 
cell-types. Different populations of GABAergic neurons within the DRN project to either 
local serotonin-expressing neurons (Challis et al. 2013), or to other brain regions such as 
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the prefrontal cortex, nucleus accumbens, and lateral hypothalamus (Bang and Commons 
2012). Local circuit GABAergic neurons mono-synaptically contact DRN serotonergic 
neurons and inhibit their activity, impacting on DRN-associated behaviours (Challis et al. 
2013; Soiza-Reilly et al. 2013). Thus, the activation of alpha1-GABAARs on DRN 
GABAergic interneurons is likely to decrease excitability of these interneurons and result in 
a disinhibition of the principal cells with a consequent increase in serotonin release. 
Conversely, activation of alpha1-GABAARs on the select population of rostrally-located 
serotonergic neurons should decrease their neuronal activity leading to decreased 
serotonin release. Alpha1 subunit expressing serotonergic neurons were enriched 
dorsally, in rostral DRN, such anatomically located DRN serotonin neurons project to the 
caudate putamen, amygdala, thalamus, nucleus accumbens and the neocortex (O'Hearn 
and Molliver 1984; Waselus et al. 2011). It is tempting to speculate that DRN serotonin 
release within these brain regions must be under the strict temporal control of somatically 
located, fast synaptic GABAAR neurotransmission mediated by alpha1 containing GABAAR 
subtypes, rather than dendritic, slower synaptic GABAAR neurotransmission mediated by 
alpha2 and alpha3 containing GABAARs. The functional significance of alpha1 subunit 
containing GABAAR-mediated inhibition of specific, topographically organised DRN 
serotonin neurons remains to be determined. However, it may shape DRN serotonin 
release in a brain region specific manner and contribute to the involvement of the DRN in a 
vast array of behaviours  
 
The GABAAR alpha2 and 3 subunits in the DRN  
The overall appearance of the GABAAR alpha2/3 subunit immunoreactivity differed greatly 
to that of the alpha1 subunit. GABAAR alpha2/3 subunit labelling was clustered and 
enriched on the dendritic domains of DRN serotonergic neurons. The quantitative data 
revealed that 45% and 36% of NL2 clusters located on TPH-immunopositive profiles co-
localised with alpha2 and alpha3 subunit clusters, respectively, indicating that the majority 
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of GABAergic postsynaptic inhibitory currents on DRN principal neurons are mediated by 
alpha2/3-GABAARs. A further point of note was the proportion of GABAAR alpha3 
immunoreactive clusters which did not co-localise with NL2. This pattern of expression, 
which did not appear to be restricted to particular serotonergic neurons, suggests a 
component of non-synaptically located alpha3-GABAAR subtypes, which predictably might 
mediate tonic GABAergic inhibition in the DRN. Indeed, in our recent functional study 
using somatic whole-cell patch clamp recordings of acute DRN slices (Maguire et al. 
2013), GABAAR-mediated tonic inhibitory currents were detectable, but only in ~30% of 
serotonergic neurons. The apparent discrepancy between the proportion of serotonergic 
neurons exhibiting a GABA-mediated tonic conductance and the immunohistochemistry 
may result from the preferential location of GABAAR alpha3 subunit immunoreactive 
clusters on TPH-immunopositive dendrites (Fig. 8) precluding their detection with somatic 
recordings. Indeed, cell-types, such as the principal neurons of the basolateral amygdala, 
in which robust alpha3-GABAARs mediated tonic currents are detectable, have GABAAR 
alpha3 subunit immunoreactivity enriched on their somata; see Fig. 3G of (Marowsky et al. 
2012). Alternatively, the levels of ambient GABA experienced by some neurons may not 
be sufficient (greater than 10 µM- see Maguire et al., 2013) to activate such extrasynaptic 
alpha3-GABAARs.  
 
The importance of such persistent patterns of inhibition in particular neurons is likely to 
indicate the requirement for sustained modulation of neuronal activity compared to brief 
periods of phasic inhibition. This pattern of persistent inhibitory regulation of neuronal 
activity could be particularly important for diffuse modulatory systems such as serotonergic 
pathways which provide brain-wide release of their neurotransmitters during the 
processing of on-going sensory stimuli, or a specific behavioural state. In turn, alterations 
in the levels of expression of such extrasynaptically located GABAAR subtypes might 
dynamically regulate serotonin release resulting in altered behaviours or even DRN-
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serotonin associated disorders. Behavioural inflexibility, the inability to thrive in a 
constantly changing environment is a feature of mood disorders. Therefore, in terms of 
regulating mood for example, the balance between slow persistent and fast, brief pulses of 
inhibition may provide the neuron with the flexibility to seamlessly adapt its firing pattern in 
response to external inputs such as various stressors. Thus, the changes in 
synaptic:extrasynaptic expression ratios of particular GABAAR subunits and the 
accompanying changes in phasic and tonic currents in the context of animal models of 
mental illnesses could provide novel insights to the changes in neuronal activity which 
underlie such behaviour.  
 
The GABAAR gamma2 subunit in the DRN 
GABAAR gamma2 subunit heterozygous knockout mice display reduced GABAAR 
clustering and exhibit an anxiogenic-like behavioural phenotype (Crestani et al. 1999) 
which infers a role for gamma2-GABAARs mediated inhibition in such disorders. Indeed, 
classical benzodiazepine agents with anxiolytic activity potentiate GABAergic 
neurotransmission preferentially at gamma2-alpha2/3-beta-GABAAR subtypes (Rudolph 
and Knoflach 2011). The evidence for the involvement of alpha2-GABAARs in anxiety and 
anxiolytic drug effects is clear (Low et al. 2000; Smith et al. 2012; Engin et al. 2012; 
Koester et al. 2013). It is thus surprising that in this study, immunoreactivity for the 
GABAAR gamma2 subunit was enriched on DRN non-serotonergic cells which co-
expressed the GABAAR alpha1 and 3 subunits with noticeably lower levels of GABAAR 
gamma2 signal associated with GABAAR alpha2/3 subunit immunoreactivity on 
serotonergic neurons, suggesting a lesser role for alpha2-GABAARs in DRN-
benzodiazepine mediated anxiolysis. The use of mutant mouse models in which specific 
GABAAR alpha subunits are either rendered insensitive to benzodiazepines (Wieland et al. 
1992; Benson et al. 1998; Rudolph and Knoflach 2011) or deleted, in a cell-specific 
manner (Wisden 2010; Kos 2004) will be invaluable in determining the precise cell-types 
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which mediate the behavioural effects of ingested GABAAR-specific ligands or possibly 
underlie associated disorders. 
 
Stress and GABAAR expression in the DRN 
Overwhelming evidence indicates that GABAARs are integral to DRN stress circuitry, 
although their precise roles are difficult to unequivocally define. Acute swim stress in rats 
results in an increase in the frequency of GABAergic miniature inhibitory postsynaptic 
currents on serotonergic neurons (Lamy and Beck 2010), while five days of social defeat 
attenuates inhibitory synaptic input onto serotonergic neurons (Crawford et al. 2013). 
Furthermore, the application of the stress neuropeptide CRH to acute slices of the DRN 
has both direct and indirect effects on GABAergic currents onto serotonergic neurons 
(Kirby et al. 2008). The current data build on these studies by providing a high resolution 
analysis of the changes in the expression of specific GABAAR subunits within identified 
cell-types of the DRN.  
 
Multiple and distinct mechanisms are likely in place to modulate this stress-induced 
GABAAR alpha3 subunit expression. Glucocorticoids, as a result of the HPA activation, are 
central molecular players of the stress response and signal both peripherally and centrally 
to engage metabolic and neural process required for dealing with adversity. As such, the 
signal transduction cascades initiated by such steroid hormones and their derivatives are 
well placed to dynamically regulate gene transcription in response to an external stimulus. 
Chronic exposure to glucocorticoids has been shown to elevate GABAAR subunit mRNA 
expression within the hippocampus (Orchinik et al. 1995). As the DRN expresses high 
levels of glucocorticoid receptor (Aronsson et al. 1988), glucocorticoid mediated regulation 
of transcription may mediate the stress induced increases in GABAAR subunit mRNA in 
the DRN shown here. Interestingly, GABAAR subunit mRNA expression within the LC, a 
region of enriched glucocorticoid receptor expression, was not significantly affected by this 
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stress protocol. The obvious caveat is that stress might affect GABAAR subunit expression 
within the LC at the protein level. Nevertheless, this suggests that multiple mechanisms 
are in place to regulate GABAAR mRNA expression in a brain region specific manner. 
Other potential mechanisms may include epigenetic influences such as dinucleotide 
methylation of cytosine-phosphodiester bond-guanine (CpG) islands (Weaver et al. 2006) 
and histone modification (Renthal et al. 2007; Uchida et al. 2011). Both mechanisms have 
received considerable attention recently in mediating the effects of environmental factors 
on brain function, behaviours and psychiatric diseases (Tsankova et al. 2007). 
Bioinformatic analysis of the Gabra3 gene revealed the absence of a CpG island within or 
near the Gabra3 promotor sequence; this suggests that if epigenetic mechanisms do 
contribute to the regulation of Gabra3 gene transcription, it is unlikely to be mediated by 
changes in the methylation status of CpG dinucleotides. Several different types of post 
translational histone modifications exist. However, acetylation and methylation are the 
most widely studied. Histone deacetylase inhibitors have been shown to influence 
GABAAR subunit mRNA expression in the nucleus accumbens (Kennedy et al. 2013). 
Therefore, it is possible that post translational histone modifications may also contribute to 
stress induced alterations in GABAAR subunit mRNA plasticity within the DRN. Evaluation 
of epigenetic changes in GABAAR subunit expression could represent new avenues for 
investigating how environmental factors shape brain function and behaviour. 
 
In addition to increased GABAAR alpha3 mRNA levels, we also show that stress increases 
the expression of the GABAAR alpha3 subunit at the protein level. Through extensive 
intracellular signalling cascades, encompassing a vast array of proteins, trafficking 
pathways dynamically regulate the distribution and number of diverse GABAAR subtypes 
within the cell membrane (Luscher et al. 2011). Due to the complexity of GABAAR 
trafficking, multiple points along the secretory or endocytotic pathway may be targeted to 
influence GABAAR expression and in turn neuronal activity. Clathrin-mediated endocytosis 
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is an important factor in regulating GABAAR expression (Kittler et al. 2000). The 
phosphorylation status of beta subunits of GABAARs has a major role in regulating the 
clathrin mediated endocytosis of such receptors. When specific residues of the GABAAR 
beta subunits are phosphorylated, the affinity between the GABAAR beta subunit and 
clathrin adaptor protein (AP2) is reduced thereby attenuating receptor endocytosis (Kittler 
et al. 2005). A number of proteins contribute to the phosphorylation of GABAAR subunits 
including protein kinase A, C and B (PKA, PKC, PKB) as well as calmodulin dependent 
kinase II (CaMKII). Furthermore, neurosteroids have recently been implicated in the 
phosphorylation and membrane insertion of GABAARs (Abramian et al. 2014). A potential 
trigger of such secondary messenger cascades is likely to the endogenous stress 
hormone CRH. Receptors for CRH are coupled to diverse intracellular signalling pathways 
which activate kinase pathways including PKA and PKC (Hauger et al. 2009). Since CRH 
together with both receptors for CRH, CRH-R1 and R2 are expressed and mediate the 
effects of stress on DRN neuronal activity (Kirby et al. 2000), CRH is the likely candidate 
through which stress can dynamically regulate the expression of GABAAR subtypes via 
PKA or PKC mediated phosphorylation of GABAAR beta subunits. 
 
One particularly intriguing finding of this study was that repeated stress impacts upon 
GABAAR alpha3 subunit expression at both mRNA and protein levels. This is surprising as 
the constitutive activity of endoplasmic reticulum (ER) degradation enzyme results in it 
being more efficient for a cell to recycle endocytosed GABAARs rather than transporting 
newly assembled receptors from the ER to the cell membrane. Thus, the reach of 
environmental stimuli to both the gene and protein levels suggests that even this mild 
stress paradigm exerted a significant demand on the alpha3-GABAAR machinery of the 
cell necessitating the engagement of a variety of intracellular signalling cascades including 
those likely to be less energy efficient. These processes are likely to serve the cell well 
during short-term bouts of stress, as is the case in this paradigm. Indeed, since we 
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deliberately used a mild stress protocol which numerous studies have shown does not 
manifest in a chronic stress phenotype, it is speculative that such stress-induced increases 
in the levels of GABAAR alpha3 subunit expression parallels or contributes to adaptive, 
rather than maladaptive responses  to stressful life experiences. In turn, during severe 
chronic periods of stress, especially episodes which trigger mental disorders, such 
molecular pathways could be exhausted. Thus, the expectation is that longer periods of 
stress will eventually manifest in lower levels of GABAAR expression within the DRN. If so, 
this could lead to, for example, an anxiogenic profile which might be ameliorated by 
benzodiazepine treatment which augments the activity of the ensuing lower levels of 
GABAARs. Such data could provide a wholly novel avenue on the biological mechanisms 
which underpin adaptive or maladaptive stress pathways and may contribute to the 
identification of newer and more effective drug targets for the treatment of stress-related 
psychiatric disorders. 
  
In conclusion, the study demonstrates the molecular identity and the location of the 
GABAAR subunits which are likely to determine some of the most salient effects of GABA 
within the DRN-serotonin system, which are known to influence the excitability of the DRN 
and consequently behaviour. Furthermore, the evidence that stress directly impacts on the 
level of expression of the GABAAR alpha3 subunit provides a distinct molecular target for 
future studies investigating the mal/adaptive consequences of stress-induced alterations in 
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Immunohistochemical localisation of inhibitory synaptic marker proteins on serotonergic 
neurons of the DRN 
(a1) shows gephyrin immunoreactive clusters enriched on dendritic compartments of 
putative serotonergic neurons identified with tryptophan hydroxylase (TPH) 
immunoreactivity, with notably fewer gephyrin clusters present on somatic domains. (a2) 
shows that neuroligin2 (NL2) immunoreactive clusters displayed a similar distribution 
pattern to that of gephyrin, with NL2 immunoreactivity being enriched on TPH-
immunopositive dendrites. (a3) numerous NL2 clusters co-localise with gephyrin. (b) 
quantification of the density of individual and colocalised gephyrin and NL2 
immunoreactive clusters. Scale bars 5 μm. 
 
Fig. 2 
Confirmation of the specificity of the immunoreactivity patterns produced by antibodies 
against the GABAAR alpha1, alpha2 or alpha3 subunits in the DRN using tissue from WT 
and GABAAR subunit-specific gene-deleted mice processed and imaged under identical 
conditions 
(a1) shows an overview of TPH immunoreactivity in tissue from WT (alpha1+/+) mouse. 
(a2) shows an overview of the pattern of GABAAR alpha1 subunit immunoreactivity in the 
DRN of WT tissue with extensive signal evident throughout most of the DRN although the 
signal is particularly enriched in the lateral wing sub-regions. (b1) shows an overview of 
TPH immunoreactivity in tissue from the DRN of a GABAAR alpha1 subunit-specific gene-
deleted mouse (alpha1-/-). No differences in the levels of TPH signal in the DRN of WT and 
alpha1-/-mice were detectable (b2) shows that no specific GABAAR alpha1 subunit 
immunoreactivity was detectable in tissue from an alpha1-/- mouse. (c1) shows the 
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localisation of NL2 on tryptophan hydroxylase (TPH) immunoreactive profiles of the DRN 
indicating the distribution of putative inhibitory synapses on serotonergic processes within 
the DRN of WT mouse. (c2) shows the pattern of GABAAR alpha2 subunit 
immunoreactivity in the same field of view. (d1) shows the distribution and intensity of TPH 
and NL2 immunoreactivity in the DRN of an alpha2-/-mouse. (d2) shows that no specific 
GABAAR alpha2 subunit immunoreactivity was detectable in tissue from alpha2
-/- mice.  
(e1) shows TPH immunoreactivity in the DRN of WT mouse. (e2) shows the pattern of 
GABAAR alpha3 subunit immunoreactivity in the same field of view. Note how GABAAR 
alpha3 subunit immunoreactivity closely follows the pattern of TPH immunoreactivity. (f1) 
an overview of the pattern of TPH and (f2) GABAAR alpha3 subunit immunoreactivity in the 
DRN of an alpha3-/- mouse showing the absence of  any specific signal for this subunit. 
Scale bars (a, b, e, f) 50 μm; (c, d) 10 μm. 
 
Fig. 3 
Immunolocalisation of the GABAAR alpha1 subunit in neurochemically diverse cell-types of 
the DRN   
(a1 – a3) the GABAAR alpha1 subunit immunoreactive profiles are widely distributed 
throughout the DRN. (A1) an overview, taken from the ventromedial sub-region of the DRN 
showing an overlay of the immunoreactive signals for the GABAAR alpha1 subunit, the 
dendritic marker protein microtubule associated protein 2 (MAP2) and TPH indicating that 
such GABAAR alpha1 subunit immunopositive cells comprise a significant proportion of the 
neurons composing the DRN. (a2) is a magnified view of the inner boxed area in (a1) 
showing GABAAR alpha1 subunit immunoreactivity which is closely associated with 
numerous MAP2 immunolabelled dendrites as well as being on a soma (asterisk) which in 
(a3) is TPH-immunonegative. (a3) shows TPH immunoreactivity associated with somatic 
as well as dendritic (arrowheads) profiles. Images from (b) and (c) were acquired from the 
dorsal and ventral regions of the DRN respectively and demonstrate GABAAR alpha1 
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subunit immunoreactivity in neurochemically distinct cell-types and its varying association 
with gephyrin immunoreactivity across these sub-regions of the DRN. Immunoreactivity for 
the GABAAR alpha1 subunit was evident in cells which were (b1) TPH immunopositive (#), 
(b2, c1, 2) TPH immunonegative, GAD67-GFP immunopositive (*) and (b1 & 2) a discrete 
population of cells not labelled by either TPH or GAD67-GFP (+). (b3) shows the strong 
association of gephyrin with GABAAR alpha1 subunit immunoreactive dendrites apart from 
(c3) which shows that the GAD67-GFP GABAAR alpha1 subunit immunolabelled neurons 
shown in (b,c2) exhibit a relative enrichment of gephyrin immunoreactivity on their somata 
and proximal dendrites. In panel (b), the inserts shows magnified views of the boxed 
areas. (b4) and (c4) are overlays of all the individual (b) and (c) panels respectively. Scale 
bar 10 μm. 
 
Fig. 4 
GABAAR alpha1 subunit-immunopositive TPH labelled cells are differentially distributed 
throughout the rostra-caudal and ventro-medial extents of the DRN.  
(a1, b1, c1) schematics of the anatomical coordinates  and the DRN sub-nuclei whereby 
the number of total TPH and TPH-GABAAR alpha1 subunit-immunopositive cells  at the 
rostral, midline and caudal planes were quantified respectively according to (Paxinos and 
Franklin 2004). (a2, b2, c2) graphical representation of the number of total TPH and TPH-
GABAAR alpha1 subunit-immunopositive cells within the different DRN sub-nuclei at the 
rostral, midline and caudal planes respectively. Bars represent means with lines indicating 
SEM. N = 3 animals. (a3, b3, c3) shows the proportion of TPH-GABAAR alpha1 subunit-
immunopositive cells relative to the total number of TPH immunopositive cells at the 
rostral, midline and caudal planes respectively. lDRN, lateral region of the DRN; ifDRN, 







Immunolocalisation of the GABAAR alpha2 subunit in the DRN  
(a1) shows an overview of NL2 immunoreactivity in the DRN indicating the distribution of 
putative inhibitory synapses. (a2) shows an overview of GABAAR alpha2 subunit 
immunoreactivity. Note that the immunoreactive clusters are largely uniformly sized and 
associated with TPH immunopositive dendrites with only dispersed clusters evident on 
TPH immunopositive somata (asterisks).  (a3) an overlay of (a1) and (a2) indicating the 
extensive co-localisation of GABAAR alpha2 subunit clusters with those of NL2. (b) 
magnified views of the boxed regions in (a). The arrowheads point to (b1) NL2 
immunopositive clusters and (b2) GABAAR alpha2 subunit immunopositive clusters which 
in (b3) co-localise. Note that some NL2 immunopositive clusters do not co-localise with 
GABAAR alpha2-immunoreactive clusters (arrows). Scale bar (a) 10 μm, (b) 5 μm. 
 
Fig. 6 
Immunolocalisation of the GABAAR alpha3 subunit in the DRN  
 (a1) shows that NL2 immunoreactivity preferentially located on TPH immunopositive 
dendrites. (a2) GABAAR alpha3 subunit-immunoreactive clusters were preferentially 
localised to TPH immunopositive dendrites rather than somata and appeared more 
variable in both size and shape when compared with those of the GABAAR alpha2 subunit 
(Figure 5). (a3) a subpopulation of NL2 immunoreactive clusters present on TPH 
immunopositive profiles co-localised with the notably larger sized GABAAR alpha3 subunit 
clusters (arrowheads). In contrast, the smaller sized GABAAR alpha3 subunit clusters 
together with the diffuse signal did not co-localise with NL2-immunoreactive signal 
(arrows).  The inserts in (a1-3) are magnified views of the boxed areas in the respective 
panels. (b) shows the distribution of GABAAR alpha3 subunit immunoreactivity in the 
thalamic reticular nucleus (nRT), a brain region known to express only this GABAAR alpha 
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subunit and specifically in inhibitory synapses. (b1) NL2 immunoreactive puncta decorated 
parvalbumin labelled processes within the nRT. (b2) GABAAR alpha3 subunit 
immunoreactivity presented as large distinct clusters associated with parvalbumin 
immunopositive positive profiles. (b3) shows that the majority GABAAR alpha3 subunit 
immunoreactivity colocalise with NL2 immunoreactivity within the nRT indicating that the 
association of this subunit with inhibitory synaptic markers is cell-type specific. (c) Sparse, 
discrete GABAAR alpha3 subunit immunopositive clusters decorated non-serotonergic, 
GABAAR alpha1 subunit, GAD67-GFP immunopositive profiles in the DRN. (c1) shows 
GABAAR alpha3 subunit immunoreactive clusters on TPH-immunopositive profiles 
(arrowheads) whilst a proportion of GABAAR alpha3 immunoreactive clusters were not 
associated with TPH immunopositive profiles (arrows). (c2) shows GABAAR alpha3 
subunit clusters not associated with TPH-immunopositive profiles co-localised with 
GABAAR alpha1 immunopositive signal. (c3) some of these GABAAR alpha3 subunit-
immunopositive, TPH-immunonegative neurons were immunopositive for GFP-GAD67 
signal. Scale bar 10μm. 
 
Fig. 7 
The constitutive brain-wide deletion of the GABAAR alpha1 subunit increases GABAAR 
alpha3 subunit immunoreactivity the DRN  
(a1, b1) no discernible differences were evident in the intensity of gephyrin and TPH 
immunoreactivity in the DRN of WT (alpha1+/+) and GABAAR alpha1 subunit-specific gene-
deleted (alpha1-/-) mouse. This also serves to confirm that the comparative images were 
taken at identical focal planes (a2, b2) the deletion of the alpha1 subunit results in a 
dramatic increase in the intensity of GABAAR alpha3 subunit immunoreactivity. Note that 
WT and alpha1+/+ mouse tissue was processed, reacted and imaged under identical 
conditions. (a3, b3) An overlay shows an apparent increase in the extent of co-localisation 
between gephyrin and GABAAR alpha3 subunit immunoreactive clusters similar to the 
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degree of GABAAR alpha1 subunit-gephyrin co-localisation in Figure 3b. The insert in (B3) 
shows dense GABAAR alpha3 subunit immunoreactivity which is co-localised with that of 
gephyrin and outlines the somato-dendritic plasma membrane of a non-TPH labelled cell 
in the DRN, reminiscent of GABAAR alpha1 subunit-immunopositive neurons shown in 
Figure 3b. There was no evidence of such GABAAR alpha3 subunit-enriched cells in DRN 
tissue from WT mice. Scale bars 10μm. 
 
Fig. 8 
The association between GABAAR gamma2 subunit immunoreactivity with 
immunoreactivity for the GABAAR alpha1, 2 and 3 subunits in the DRN  
(a) shows that the majority of the GABAAR gamma2 subunit immunoreactivity in the DRN 
is contained on GABAAR alpha1 subunit GAD67-GFP-immunopositive neurons. (a1) 
shows immunoreactivity for non-TPH expressing cells which are immunopositive for GFP-
GAD67 and likely represent local-circuit GABAergic interneurons. (a2) these GAD67-GFP-
immunopositive neurons exhibited strong immunoreactivity for the GABAAR gamma2 
subunit which was localised to their somatic and dendritic compartments. (a3) GABAAR 
alpha1 subunit immunoreactivity patterns closely followed that of the GABAAR gamma2 
subunit being localised to the somatic and dendritic domains of these GAD67-GFP-
immunopositive neurons. (a4) shows widespread co-localisation between GABAAR 
gamma2 subunit and GABAAR alpha1 subunit immunoreactive clusters within the DRN. 
The insert is a magnified view of a GAD67-GFP immunopositive neuron (*). (b-c) a 
proportion of GABAAR gamma2 subunit immunopositive puncta co-localised with GABAAR 
alpha2 subunit and GABAAR alpha3 subunit clusters on TPH immunopositive profiles. 
Arrows highlight GABAAR gamma2 immunoreactive puncta not co-localised with 
alpha2/alpha3 puncta, whereas arrowheads highlight GABAAR gamma2 puncta co-
localised with alpha2/alpha3 puncta. (b1) and (c1) show GABAAR gamma2 subunit 
immunoreactive clusters on the somatic and dendritic compartments, but enriched on the 
47 
 
dendritic domains of TPH immunopositive and TPH immunonegative profiles (arrows). (b2, 
c2) shows GABAAR alpha2 and alpha3 subunit immunoreactivity decorating the dendritic 
and somatic domains of TPH immunopositive profiles. (b3, c3) GABAAR gamma2 subunit 
immunoreactive clusters displayed minimal co-localisation with GABAAR alpha2 and 
alpha3 subunit immunoreactive clusters. A magnified view of the boxed area highlights the 
sparse co-localisation of GABAAR gamma2 subunit immunoreactive clusters with GABAAR 
alpha2 and with alpha3 immunoreactive clusters (arrowheads). Scale bars 10 μm. 
 
Fig. 9 
Corticotrophin releasing hormone (CRH) immunoreactive puncta are associated with 
gephyrin and GABAAR alpha1 subunit immunoreactive clusters on TPH and non-TPH 
profiles within the DRN 
(a) shows isolated CRH immunoreactive puncta closely opposed to gephyrin 
immunoreactive clusters on TPH immunopositive profiles which are likely to represent  
GABAAR alpha2-3 subunit immunopositive synapses (arrowheads). (b) shows intense 
CRH immunoreactive signal closely opposed to GABAAR alpha1 subunit immunoreactivity 




Repeated restraint stress alters the mRNA and protein levels of specific GABAAR subunits 
within the DRN 
(a) the relative expression levels of mRNA encoding for GABAAR subunits above or below 
control. In the DRN, the influence of stress on levels of mRNA expression of GABAAR 
subunits was subunit specific, with the alpha2 and alpha3 subunit encoding mRNA levels 
significantly increased above control. In contrast, no significant differences in the GABAAR 
alpha1 and gamma2 subunit encoding mRNA levels were observed. (N = 14 animals per 
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group). (b) and (c) are representative images of the levels of GABAAR alpha3 subunit 
immunoreactivity on TPH immunopositive profiles within the DRN in tissue from control 
and stress animals respectively, processed and imaged under identical conditions (d) 
graphical representation of the quantification of the stress-induced changes in GABAAR 
alpha3 subunit and gephyrin immunoreactivity on TPH immunopositive profiles within the 
DRN. Bars represent means with lines indicating SEM. N = 3 animals per group, *p <0.05, 





















































Rabbit Werner Sieghart,  
Antigen sequence -α1N 
amino acids 1-9 
Rabbit # 21/7,  
bleed # 04/10/1999 
1:5000 (Pirker et al. 2000; 
Poltl et al. 2003; 






Guinea pig Jean-Marc Fritschy, 
University of Zurich, 
Zurich, Switzerland 
Antigen sequence α 2N.  
amino acids 1-9  
1:1000 (Fritschy and 
Mohler 1995; 





Guinea pig Jean-Marc Fritschy, 
University of Zurich, 
Zurich, Switzerland 
Antigen sequence α 3N.  
amino acids 1-15  
1: 5000 (Corteen et al. 






Guinea pig Jean-Marc Fritschy, 
University of Zurich, 
Zurich, Switzerland 
Antigen sequence  
Antigen sequence α 3N.  
amino acids 1-29 




Rabbit Synaptic systems 
#224 003 




extensively used in 
the literature 
(Essrich et al. 1998; 
Eyre et al. 2012; 











Gephyrin Mouse Synaptic Systems 
#147 021 
1: 500 (Pfeiffer et al. 1984) 
Neuroligin2 Rabbit Synaptic Systems 
#129 203 
1: 1000 Labelling pattern as 
published with 
other antibodies.  
GFP Chicken Aves Labs Inc. 
#GFP-1020 
1: 5000  
Parvalbumin Mouse Swant 
#253 




releasing hormone  
Guinea Pig Peninsula Laboratories  
#T-5007 










Schedule of the repeated restraint stress protocol 
 
 
Day 1 2pm: restraint 
Day 2 10am: restraint 
Day 3 2pm: animal placed in cage with restrainer but not restrained 
Day 4 10am: ‘escapable’ restraint  
Day 5 2 pm: restraint 
Day 6 10am: ‘escapable’ restraint 
Day 7 10am: restraint 





Primers and probes used for qRT-PCR 
 
 
Gene Primers and Probes (Life Technologies™) 
gabra1 Mm00439046_m1 
gabra2 Mm00433435_m1 
gabra3 Mm01294271_m1 
gabrg2 Mm00433489_m1 
gapdh Mm99999915_g1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
51 
 
 
 
Fig1 
52 
 
 
Fig2 
53 
 
 
Fig3 
54 
 
 
Fig4 
55 
 
 
Fig5 
56 
 
 
Fig6 
57 
 
 
Fig7 
58 
 
 
Fig8 
59 
 
 
Fig9 
60 
 
 
Fig10 
 
